abstract |
The present invention provides methods for obtaining mesenchymal stem cell (MSC)-derived cells of chondro-osteoblastic lineage from MSC. The invention also relates to a population of MSC-derived cells of chondro-osteoblastic lineage obtained by the methods, a pharmaceutical formulation comprising the population of MSC-derived cells of chondro-osteoblastic lineage, and their use in the treatment of a subject in need of transplantation of cells of chondro-osteoblastic lineage. |